Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Proteomic and Glycomic Markers to Differentiate Lung Adenocarcinoma from COPD.

Szabo M, Hajba L, Kun R, Guttman A, Csánky E.

Curr Med Chem. 2018 Oct 17. doi: 10.2174/0929867325666181017112939. [Epub ahead of print]

PMID:
30332938
2.

Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis.

Magorivska I, Döncző B, Dumych T, Karmash A, Boichuk M, Hychka K, Mihalj M, Szabó M, Csánky E, Rech J, Guttman A, Vari SG, Bilyy R.

Autoimmunity. 2018 May;51(3):111-117. doi: 10.1080/08916934.2018.1468886. Epub 2018 May 7.

PMID:
29733234
3.

Molecular glycopathology by capillary electrophoresis: Analysis of the N-glycome of formalin-fixed paraffin-embedded mouse tissue samples.

Donczo B, Szarka M, Tovari J, Ostoros G, Csanky E, Guttman A.

Electrophoresis. 2017 Jun;38(12):1602-1608. doi: 10.1002/elps.201600558. Epub 2017 Mar 23.

PMID:
28334446
4.

Capillary electrophoresis analysis of N-glycosylation changes of serum paraproteins in multiple myeloma.

Kovacs Z, Simon A, Szabo Z, Nagy Z, Varoczy L, Pal I, Csanky E, Guttman A.

Electrophoresis. 2017 Sep;38(17):2115-2123. doi: 10.1002/elps.201700006. Epub 2017 Feb 21.

PMID:
28116769
5.

Liquid phase separation methods for N-glycosylation analysis of glycoproteins of biomedical and biopharmaceutical interest. A critical review.

Hajba L, Csanky E, Guttman A.

Anal Chim Acta. 2016 Nov 2;943:8-16. doi: 10.1016/j.aca.2016.08.035. Epub 2016 Aug 26. Review.

PMID:
27769380
6.

[Chylothorax as a complication of coronary artery bypass grafting operation].

Szabó M, Jáger M, Krizsó E, Gilányi I, Leny A, Szűcs G, Csánky E.

Orv Hetil. 2012 Apr 8;153(14):553-8. doi: 10.1556/OH.2012.29341. Hungarian.

PMID:
22450144
7.

Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.

Guergova-Kuras M, Kurucz I, Hempel W, Tardieu N, Kádas J, Malderez-Bloes C, Jullien A, Kieffer Y, Hincapie M, Guttman A, Csánky E, Dezso B, Karger BL, Takács L.

Mol Cell Proteomics. 2011 Dec;10(12):M111.010298. doi: 10.1074/mcp.M111.010298. Epub 2011 Sep 26.

8.

Chronic obstructive pulmonary disease-specific gene expression signatures of alveolar macrophages as well as peripheral blood monocytes overlap and correlate with lung function.

Poliska S, Csanky E, Szanto A, Szatmari I, Mesko B, Szeles L, Dezso B, Scholtz B, Podani J, Kilty I, Takacs L, Nagy L.

Respiration. 2011;81(6):499-510. doi: 10.1159/000324297. Epub 2011 Mar 23.

9.

Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.

Penyige A, Poliska S, Csanky E, Scholtz B, Dezso B, Schmelczer I, Kilty I, Takacs L, Nagy L.

BMC Med Genet. 2010 Nov 2;11:152. doi: 10.1186/1471-2350-11-152.

10.

Differentially expressed microRNAs in small cell lung cancer.

Miko E, Czimmerer Z, Csánky E, Boros G, Buslig J, Dezso B, Scholtz B.

Exp Lung Res. 2009 Oct;35(8):646-64. doi: 10.3109/01902140902822312.

PMID:
19895320
11.
12.

Monoclonal antibody proteomics: discovery and prevalidation of chronic obstructive pulmonary disease biomarkers in a single step.

Csanky E, Olivova P, Rajnavolgyi E, Hempel W, Tardieu N, Katalin ET, Jullien A, Malderez-Bloes C, Kuras M, Duval MX, Nagy L, Scholtz B, Hancock W, Karger B, Guttman A, Takacs L.

Electrophoresis. 2007 Dec;28(23):4401-6.

PMID:
18041035
13.

[Successful renal transplantation following lung transplantation: a survey of the first Hungarian case].

Csánky E, Asztalos L, Vaskó A, Szucs I, Dévényi K, Szilasi M, Balla J.

Orv Hetil. 2007 Nov 11;148(45):2147-51. Hungarian.

PMID:
17984027
14.

[Adenomatoid malformation as peripheral round shadow in lung].

Vaskó A, Kovács J, Fodor A, Szilasi M, Arkossy P, Csánky E.

Orv Hetil. 2005 Apr 24;146(17):803-6. Hungarian.

PMID:
17918637
15.

[The role of volume reduction surgery in the therapy of early stage chronic obstructive pulmonary disease].

Vaskó A, Kiss S, Dévényi K, Ordög C, Szilasi M, Csánky E.

Orv Hetil. 2006 Oct 29;147(43):2091-6. Review. Hungarian.

PMID:
17297756
16.

[Patient's selection for lung transplantation, and management during the waiting time].

Csánky E.

Orv Hetil. 2006 Oct 29;147(43):2069-74. Hungarian.

PMID:
17297753
17.
18.

[Therapy of patients with end-stage pulmonary disease. Review of lung transplantation based on four cases of our own].

Csánky E, Szabó P, Vaskó A, Szilasi M, Lang G, Klepetko W.

Orv Hetil. 2003 Apr 13;144(15):691-9. Review. Hungarian.

PMID:
12774428
19.

Genetic polymorphism of the human tumor necrosis factor region in insulin-dependent diabetes mellitus. Linkage disequilibrium of TNFab microsatellite alleles with HLA haplotypes.

Monos DS, Kamoun M, Udalova IA, Csanky E, Cizman B, Turetskaya RL, Smirnova JB, Zharkov VG, Gasser D, Zmijewski CM, et al.

Hum Immunol. 1995 Oct;44(2):70-9.

PMID:
8847231
20.

Potentiation of HIV envelope glycoprotein and other immunogens by endotoxin (ET) and its molecular fragments.

Kovats E, Somlyo B, Csanky E, Shi XM, Zhang YL, Coughlin RT, Nowotny A.

Int J Immunopharmacol. 1992 May;14(4):573-81.

PMID:
1521925
21.

Molecular requirements of endotoxin (ET) actions: changes in the immune adjuvant, TNF liberating and toxic properties of endotoxin during alkaline hydrolysis.

Somlyo B, Csanky E, Shi XM, Zhang YL, Kovats E, Bona-Liptak E, Nowotny AM, Tripodi D, Nowotny A.

Int J Immunopharmacol. 1992 Feb;14(2):131-42.

PMID:
1624214

Supplemental Content

Loading ...
Support Center